Recent

% | $
Quotes you view appear here for quick access.

SPDR Dow Jones Industrial Average ETF Message Board

careful_investor_wins 41 posts  |  Last Activity: Dec 1, 2015 11:26 AM Member since: Apr 8, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • careful_investor_wins careful_investor_wins Dec 1, 2015 11:26 AM Flag

    And worse of all. Amgen already filed for a drug to compete with Humira. Silly longs here can continue to stay ignorant and pretend nothing would happen. LOL. But the fact is, you cannot count on Humira sales and profits for much longer. But you can count on the $31 billion dollars of debts of this junk company will be there. LOL. So silly to own this junk stock that really has no net tangible assets left. Longs here actually own NOTHING other than owing billions of debts. LOL. This junk stock is actually worthless!

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Dec 1, 2015 11:19 AM Flag

    CELG is also working on a drug to compete with Humira.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Dec 1, 2015 11:18 AM Flag

    Actually you do not have to wait till the slow analysts to downgrade this junk stock to know you need to sell this stock. If you have been paying attention to the news, you should already know Eli Lilly is working on drug to compete with Humira.

    Sentiment: Strong Sell

  • careful_investor_wins by careful_investor_wins Dec 1, 2015 11:09 AM Flag

    LOL. Banker analysts usually are reluctant to downgrade companies because they always try to kiss up to companies in order to make money on secondary IPO, M&A, etc. It took Barclays so long to finally half-hearted admit the headwind risk to Humira sales and profits. LOL. It has to be really bad for banker analysts to down grade a stock. LOL.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Dec 1, 2015 10:47 AM Flag

    It is good that you sold out of this junk stock. Good luck to your trades too.

    Sentiment: Strong Sell

  • careful_investor_wins by careful_investor_wins Nov 30, 2015 1:53 PM Flag

    The better growth company, GILD, is a major competitor of this junk company, so it is totally valid to compare this junk to GILD. GILD earnings per share are about $12 a year while this company earnings per share are only about $4 a year. GILD stock price is only $105, but this stock price is so expensive at $58. If you apply GILD valuation to this stock, this stock should really be trading at $35. This stock can fall 40% and still is more expensive than GILD. Not to mention GILD has POSITIVE $5 billion dollars of net tangible assets left for GILD stockholders. This company has NEGATIVE $28 billion dollars of net tangible assets. This is an extremely overpriced heavily debt loaded dangerous stock. The stockholders here actually own NOTHING but owe $31 billion dollars of debts. This company is really not a stockholders' company anymore. This is already a debt holders' company. This is really a worthless stock. Very silly to buy this stock and really own NOTHING. And this valuation analysis is based on current ABBV earnings. But the most profitable drug of this company, Humira, is going to lose patent protection and face tough competitions from drugs by AMGN, CELG, LLY and many other generic drug players. The profits here will disappear soon. The current $35 valuation may not even stay for this heavily debt loaded risky junk company stock.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 30, 2015 10:36 AM Flag

    You can sell now while the stock price is still extremely expensive or wait till Humira profits disappear and the company stops paying dividends, and the stock price drops more than 40% down to its proper level, then you sell this junk stock at a lot lower level. LOL. GILD earnings per share are about $12 a year while this company earnings per share are only about $4 a year. GILD stock price is only $106, but this stock price is so expensive at $58. If you apply GILD valuation to this stock, this stock should really be trading at $35. This stock can fall 40% and still is more expensive than GILD. Not to mention GILD has POSITIVE $5 billion dollars of net tangible assets left for GILD stockholders. This company has NEGATIVE $28 billion dollars of net tangible assets. This is an extremely overpriced heavily debt loaded dangerous stock. The stockholders here actually own NOTHING but owe $31 billion dollars of debts. This company is really not a stockholders' company anymore. This is already a debt holders' company. This is really a worthless stock. Very silly to buy this stock and really own NOTHING.

    Sentiment: Strong Sell

  • careful_investor_wins by careful_investor_wins Nov 29, 2015 9:23 PM Flag

    Institutions had been selling this stock heavily. Morgan Stanley alone sold 22 million shares of this junk stock last quarter. Overall, institutions had net selling of 49 million shares of this stock in the past quarter. It is not hard to understand the dumping of institutions on this junk stock. The Humira drug that accounts for the majority of sales and profits of this company is going to lose patent protection soon. Amgen already filed for approval for a drug to compete with Humira. CELG, LLY and several other companies are all working on competing drugs too. And this junk company is dangerously overloaded with $31 billion dollars of debts too. The debts have wiped out all net tangible assets belong to shareholders already. The net tangible assets here are NEGATIVE $28 billion dollars now. It is hopeless. Stockholders here own NOTHING other than owing billions of debts. Smart institutions certainly would not want to hold a risky stock like this. There is no future in this junk stock.

    Sentiment: Strong Sell

  • careful_investor_wins by careful_investor_wins Nov 27, 2015 10:52 AM Flag

    The Humira drug that accounted for most sales and profits of this company is going to have a very tough competition. Say goodbye to sales and profits! Longs here are doomed! Very stupid to still own this heavily debt loaded junk company stock! There is no future here.
    ---
    Amgen files for U.S. approval of biosimilar to Humira
    By Bill Berkrot
    Nov 25 (Reuters) - Amgen Inc on Wednesday said it filed with U.S. health regulators seeking approval to sell its first biosimilar drug, which would be a less expensive alternative to AbbVie's Humira, the world's top-selling prescription medicine.
    Amgen said its drug, ABP 501, has demonstrated clinical equivalence and comparable safety to Humira (adalimumab) in late stage clinical trials for rheumatoid arthritis and the skin condition plaque psoriasis.
    Data to support the switching of patients from Humira to ABP 501 was included in the submission to regulators, Amgen said.
    Several companies developing biosimilars are targeting Humira, which is still growing with annual sales approaching $13 billion. Amgen said it believes it is the first to seek approval of a Humira biosimilar with the Food and Drug Administration using the new approval pathway outlined by the agency.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 24, 2015 10:35 AM Flag

    You need to look at net tangible assets. Do not just look at dividends. The net tangible assets here are negative by a whopping NEGATIVE $28 billion dollars. This is a flat broke company that is borrowing money to pay dividends. It is just like someone with an upside down mortgage on the house but still spending money like crazy in order to look rich but he is really broke. Even if this company stops paying dividends and putting all money into paying down debts, it will take years or decades to get the debts paid down. You are not owning anything here other than owing billions of debts.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 23, 2015 7:16 PM Flag

    If you know how to sell calls and puts, you can make money even if a long or short position you build is on the wrong side in the short-term. GoPro is especially easy to make money in options due to its volatility. Although my GoPro stock long position is down a bit, it has been very profitable for me in selling GPRO options. Also, you need to build a portfolio of stock positions, not just holding onto one stock. The list of high growth stocks that I provided, GILD, AAPL, MOH, GPRO, NHTC, ADPT, SKX, DHI, AFH covers different industries. So it is a diversified portfolio. When one stock is down, others may be up. And as long as those companies keep growing at high growth rates, sooner or later all of them will be up a lot to keep pace with their growth rates. When GPRO is down, you want to buy more GPRO. GPRO net tangible assets have been increasing every quarter. So GPRO intrinsic value has been increasing. It is just a matter of time for GPRO stock to gain back all the lost ground and more. On the opposite side, the net tangible assets of this company have been decreasing every quarter. The management here has been destroying the intrinsic value of the stock. The net tangible assets here are NEGATIVE $28 billion dollars now. This is a totally worthless stock. It is just a matter of time for the stock to crash big time. Do not kid yourself. This stock is down 9% for the past year. It is not going to go anywhere fast when the management here is destroying values every quarter.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 23, 2015 12:07 PM Flag

    And if you do not like GPRO, you can buy other fast growing solid companies like GILD, AAPL, MOH, NHTC, ADPT, SKX, DHI, AFH etc. Any one of them grows a lot faster than this slow company. And they are also safer financially than this heavily debt loaded junk company. This is a debtors' company already. The stock investors here own NOTHING other than owing billions of debts.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 23, 2015 12:00 PM Flag

    GPRO grew revenues by 43% year over year. That was very high growth rate. The funny thing is GPRO growth rate was very high, and it was actually a very good report from GPRO, but it missed analyst projections, so the stock was punished. And this company did not even have much growth at all, but the stock went up just because it did not miss analysts' projections. It is stupid reaction from investors. If you think about it, it was actually analysts projected numbers wrong that caused all the misses or beats. GPRO actually grows a lot faster than this company. The correct reaction should be GPRO stock goes up to match with its 43% growth rate. And unlike this junk company that has $31 billion dollars of debts, GPRO is debt free. GPRO stock cannot fall to $0 because it has no debt, but this stock can fall to $0 because this junk company is so heavy in debts. Next time inevitably the analysts project wrong again and cause GPRO to beat numbers, GPRO stock will take back all the lost ground and then some. Debt free high growth GPRO is a safer investment than this heavily debt loaded junk.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 23, 2015 10:28 AM Flag

    LOL. Are you longs here really all this stupid or what? Don't tell me you stupid longs here do not even know you can short sell stocks. And there are many different ways you can make money from stocks and options. LOL.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 23, 2015 10:16 AM Flag

    LOL. Of course I don't own this junk stock. LOL. I am not stupid. This company is only consist of debts and no net tangible assets left for stockholders. This is a debt holders' company already. Stockholders own NOTHING other than owing $31 BILLION dollars of DEBTS. LOL. If you own GILD, you actually own more than $5 billions of positive net tangible assets. For this junk, it is NEGATVE $28 billion dollars. Only idiot would own this worthless junk stock.

    Sentiment: Strong Sell

  • careful_investor_wins by careful_investor_wins Nov 19, 2015 1:39 PM Flag

    The debts of this company just keep piling higher and higher:
    Debts at the end of the first quarter this year: $10.6 billion dollars
    Debts at the end of the second quarter this year: $27 billion dollars
    Debts at the end of the third quarter this year: $31 billion dollars
    This management simply does not know how to manage money. Even if this company stops paying dividends and puts all money into paying down debts, it will take many years or even decades to pay off. And that is assume the interest rate stays low and the company does not lose sales and profits after its main drug Humira patent expires. If we have rising interest rates, it would be even worse. It is hopeless. Investing in solid companies like GILD or AAPL, etc. is better and safer than risking money in this heavily debt loaded junk.

    Sentiment: Strong Sell

  • careful_investor_wins by careful_investor_wins Nov 18, 2015 2:26 PM Flag

    It is very silly to own this heavily debt loaded junk stock. There are many other real high growth companies on the market that are growing a lot faster than this junk. Most companies on the market have a lot better balance sheets than this heavily debt loaded junk company. Sell this junk stock and buy real high growth solid stocks like GILD, AAPL, MOH, NHTC, ADPT, GPRO, SKX, DHI, AFH etc. is the best trading strategy. They all grow a lot faster than this turtle company. And they all have safer balance sheets than this heavy debt junk.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 18, 2015 2:13 PM Flag

    LOL. That was because the same topics keep coming up from you and other silly analysts and writers. LOL. If it is the same topic, the answer from me will be the same. LOL. Going forward, the most profitable drug of this company, Humira, is going to lose patent protection and may face competitions from generic drugs. And both LLY and CELG are working on drugs that will compete with Humira too. That is why the top health care fund, Turner Medical Sciences Long/Short fund, is short selling this stock. It is very bad that the most important drug of this company may lose both sales and profits soon. As for Imbruvica, this company acquired the drug through PCYC acquisition. Johnson and Johnson got into PCYC and secured half of Imbruvica profits when PCYC was below $1 billion dollars in market cap. This silly management paid $20.8 billion dollars for PCYC just to get the other half of Imbruvica profits. So silly! Johnson and Johnson management was a lot smarter than this stupid management. If the management simply spent $20.8 billion to buy market index fund, with the market PE at 16, it would have gotten the company $325 million dollars of PROFITS last quarter. It was pathetic that this company only got $304 million sales (not profits) last quarter from the Imbruvica (and probably not very profitable because PCYC was not very profitable at all) after spending $20.8 billion dollars to buy PCYC. And even worse, the extremely overpriced PCYC acquisition caused the debt level of this company to shot up to scary $31 billion dollars. It wiped out all the net tangible assets the stockholders had. The net tangible assets to the stockholders were NEGATIVE $27 billion dollars after that expensive overpriced PCYC acquisition. If it was up to me, I would have fired the management and the board for making such a bad deal and put the company into extremely risky heavy debt situation in this rising interest rate environment.

    Sentiment: Strong Sell

  • careful_investor_wins careful_investor_wins Nov 18, 2015 12:18 PM Flag

    We discussed Jefferies before. Jefferies is an investment banker. Jefferies headquarter generates a list called Franchise Picks. It is a list of large cap stocks that Jefferies salespersons use to sell stock investment to its clients. This stock was added to the list on 6/8/2015 when this stock was trading at $67. Whoever bought this stock when Jefferies added it to the picks has lost 9% already in just 5 months. LOL. Even Mallinckrodt (MNK) was added to the list on 7/21/2014. LOL. If you want to blindly follow someone else without using your own brain, be my guest. LOL. But you better sign up to be a customer of Jefferies. Because Jefferies customers will be notified to get out of this stock first. You will be late when you see it from the news that Jefferies has removed this stock from the list. LOL. Now try to use your own brain to see if Jefferies was correct or wrong to say this stock is cheap. GILD earnings per share are about $12 a year while this company earnings per share are only about $4 a year. GILD stock price is only $107, but this stock price is so expensive at $60. If you apply GILD valuation to this stock, this stock should really be trading at $35. This stock can fall 40% and still is more expensive than GILD. Not to mention GILD has $5 billion dollars of POSITIVE net tangible assets left for GILD stockholders. This company has NEGATVIE $28 billion dollars of net tangible assets. This management wasted all the money and created a gigantic hole in the pocket with $31 billion dollars of debts. The stockholders of this company really own NOTHING other than owing billions of dollars of debts. Is this stock really cheap? NO! This is an extremely expensive and risky stock!

    Sentiment: Strong Sell

  • careful_investor_wins by careful_investor_wins Nov 18, 2015 11:45 AM Flag

    It is very silly to think this is a dividend stock. GILD and AAPL pay dividends because they really have too much cash, but this company has been paying dividends with borrowed money. This stock is NOT a real dividend stock. The debts of this company have been going higher and higher every quarter and already ballooned to scary $31 BILLION dollars of debts. And those heavy debts wiped out all the net tangible assets belong to stockholders. The net tangible assets of this company are now at NEGATIVE $28 billion dollars. Stockholders of this company actually own NOTHING other than owing billions of debts. This company should have stopped paying dividends and start paying down debts. This management does not know how to manage money at all. It is just like someone with a gigantic upside down mortgage on the house but still spending money like crazy in order to look rich. This is an extremely risky stock. Your money will do better in real dividend stocks like GILD and AAPL.

    Sentiment: Strong Sell

DIA
159.39-2.73(-1.71%)Feb 10 4:00 PMEST